Sale

Giant Cell Arteritis Treatment Market

Global Giant Cell Arteritis Treatment Market Size, Forecast: By Treatment Type: Corticosteroid Therapy, Others (Monoclonal Antibody); By End Use: Hospitals, Clinics, Others; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Key Indicators for Demand, Key Indicators for Price; Competitive Landscape; 2024-2032

Global Giant Cell Arteritis Treatment Market Outlook

The global giant cell arteritis treatment market is expected to grow in the forecast period of 2024-2032 at a CAGR of 5.1%.

 

Global Giant Cell Arteritis Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America Market to be Aided by the Increasing Prevalence of the Disease.

North America holds a significant share in the global market for giant cell arteritis treatment. This can be correlated to the rising incidences of the disease among the patients. Apart from North America, Europe is also a key market for giant cell arteritis treatment. The European market is being driven by the higher standards of living and health awareness among the consumers in the region. Meanwhile, the Asia Pacific market is expected to witness a healthy growth in the coming years as well. The growing developments and technological advancements in the healthcare industry in countries such as India and China are aiding the market growth in the Asia Pacific region.

 

Giant Cell Arteritis: Market Segmentation

Giant cell arteritis (GCA), also known as temporal arteritis, is a disease of inflammation in large blood vessels, usually around the brain and head. Symptoms of GCA may include pain in the temples, flu, headache, double vision, and difficulty in opening the mouth. However, the causes of the disease are yet unknown.

 

Global Giant Cell Arteritis Treatment Market By End Use

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on the treatment type, the market is broadly classified into:

  • Corticosteroid Therapy 
  • Others (Monoclonal Antibody)

By end-use, the market can be categorized into:

  • Hospitals
  • Clinics
  • ASC’s
  • Others

The EMR report looks into the regional markets of giant cell arteritis treatment like North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Giant Cell Arteritis Treatment Market  By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Growing Elderly Population Driving the Market Growth of Giant Cell Arteritis Treatment

The increasing prevalence of giant cell arteritis across the globe is driving the market for giant cell arteritis treatment. It is generally observed in the elderly population. The increasing disposable incomes, coupled with the rising aged population, are aiding the market growth. The increasing health awareness and improving standards of living in developing countries are adding to the market growth. Governments across the globe are investing huge amounts in research and development activities in the healthcare sector. The subsequent technological advancements and developments in the healthcare industry are anticipated to provide an impetus for the growth of the market. These factors are expected to propel the global market for giant cell arteritis treatment forward over the forecast period.

 

Key Industry Players in the Global Giant Cell Arteritis Treatment Market

The report presents a detailed analysis of the following key players in the global giant cell arteritis treatment market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • F. Hoffmann-La Roche Ltd.
  • Kiniksa Pharmaceuticals, Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Tianjin Tianyao Pharmaceutical Co., Ltd.
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Treatment Type
  • End Use
  • Region
Breakup by Treatment Type
  • Corticosteroid Therapy
  • Others (Monoclonal Antibody)
Breakup by End Use
  • Hospitals
  • Clinics
  • ASC’s
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • F. Hoffmann-La Roche Ltd.
  • Kiniksa Pharmaceuticals, Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Tianjin Tianyao Pharmaceutical Co., Ltd.
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Giant Cell Arteritis Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Giant Cell Arteritis Treatment Historical Market (2018-2023) 
    8.3    Global Giant Cell Arteritis Treatment Market Forecast (2024-2032)
    8.4    Global Giant Cell Arteritis Treatment Market by Treatment Type
        8.4.1    Corticosteroid Therapy
            8.4.1.1    Historical Trend (2018-2023)
            8.4.1.2    Forecast Trend (2024-2032)
        8.4.2    Others (Monoclonal Antibody)
            8.4.2.1    Historical Trend (2018-2023)
            8.4.2.2    Forecast Trend (2024-2032)
    8.5    Global Giant Cell Arteritis Treatment Market by End Use
        8.5.1    Hospitals
            8.5.1.1    Historical Trend (2018-2023)
            8.5.1.2    Forecast Trend (2024-2032)
        8.5.2    Clinics
            8.5.2.1    Historical Trend (2018-2023)
            8.5.2.2    Forecast Trend (2024-2032)
        8.5.3    ASC’s
            8.5.3.1    Historical Trend (2018-2023)
            8.5.3.2    Forecast Trend (2024-2032)
        8.5.4    Others
    8.6    Global Giant Cell Arteritis Treatment Market by Region       
        8.6.1    North America
            8.6.1.1    Historical Trend (2018-2023) 
            8.6.1.2    Forecast Trend (2024-2032)
        8.6.2    Europe
            8.6.2.1    Historical Trend (2018-2023) 
            8.6.2.2    Forecast Trend (2024-2032)
        8.6.3    Asia Pacific
            8.6.3.1    Historical Trend (2018-2023) 
            8.6.3.2    Forecast Trend (2024-2032)
        8.6.4    Latin America
            8.6.4.1    Historical Trend (2018-2023) 
            8.6.4.2    Forecast Trend (2024-2032)
        8.6.5    Middle East and Africa
            8.6.5.1    Historical Trend (2018-2023) 
            8.6.5.2    Forecast Trend (2024-2032) 
9    North America Giant Cell Arteritis Treatment Market Analysis
    9.1    United States of America 
        9.1.1    Historical Trend (2018-2023) 
        9.1.2    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Historical Trend (2018-2023) 
        9.2.2    Forecast Trend (2024-2032)
10    Europe Giant Cell Arteritis Treatment Market Analysis
    10.1    United Kingdom
        10.1.1    Historical Trend (2018-2023) 
        10.1.2    Forecast Trend (2024-2032)
    10.2    Germany
        10.2.1    Historical Trend (2018-2023) 
        10.2.2    Forecast Trend (2024-2032)
    10.3    France
        10.3.1    Historical Trend (2018-2023) 
        10.3.2    Forecast Trend (2024-2032)
    10.4    Italy
        10.4.1    Historical Trend (2018-2023) 
        10.4.2    Forecast Trend (2024-2032)
    10.5    Others
11    Asia Pacific Giant Cell Arteritis Treatment Market Analysis
    11.1    China
        11.1.1    Historical Trend (2018-2023) 
        11.1.2    Forecast Trend (2024-2032)
    11.2    Japan
        11.2.1    Historical Trend (2018-2023) 
        11.2.2    Forecast Trend (2024-2032)
    11.3    India
        11.3.1    Historical Trend (2018-2023) 
        11.3.2    Forecast Trend (2024-2032)
    11.4    ASEAN
        11.4.1    Historical Trend (2018-2023) 
        11.4.2    Forecast Trend (2024-2032)
    11.5    Australia
        11.5.1    Historical Trend (2018-2023) 
        11.5.2    Forecast Trend (2024-2032)
    11.6    Others
12    Latin America Giant Cell  Arteritis Treatment Market Analysis
    12.1    Brazil
        12.1.1    Historical Trend (2018-2023) 
        12.1.2    Forecast Trend (2024-2032)
    12.2    Argentina
        12.2.1    Historical Trend (2018-2023) 
        12.2.2    Forecast Trend (2024-2032)
    12.3    Mexico
        12.3.1    Historical Trend (2018-2023) 
        12.3.2    Forecast Trend (2024-2032)
    12.4    Others
13    Middle East and Africa  Giant Cell Arteritis Treatment Market Analysis
    13.1    Saudi Arabia
        13.1.1    Historical Trend (2018-2023) 
        13.1.2    Forecast Trend (2024-2032)
    13.2    United Arab Emirates
        13.2.1    Historical Trend (2018-2023) 
        13.2.2    Forecast Trend (2024-2032)
    13.3    Nigeria
        13.3.1    Historical Trend (2018-2023) 
        13.3.2    Forecast Trend (2024-2032)
    13.4    South Africa
        13.4.1    Historical Trend (2018-2023) 
        13.4.2    Forecast Trend (2024-2032)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Value Chain Analysis
16    Competitive Landscape

    16.1    Market Structure
    16.2    Company Profiles
        16.2.1    F. Hoffmann-La Roche Ltd.
            16.2.1.1    Company Overview
            16.2.1.2    Product Portfolio
            16.2.1.3    Demographic Reach and Achievements
            16.2.1.4    Certifications
        16.2.2     Kiniksa Pharmaceuticals, Ltd.
            16.2.2.1    Company Overview
            16.2.2.2    Product Portfolio
            16.2.2.3    Demographic Reach and Achievements
            16.2.2.4    Certifications
        16.2.3    Teva Pharmaceutical Industries Ltd.
            16.2.3.1    Company Overview
            16.2.3.2    Product Portfolio
            16.2.3.3    Demographic Reach and Achievements
            16.2.3.4    Certifications
        16.2.4    Tianjin Tianyao Pharmaceutical Co., Ltd.
            16.2.4.1    Company Overview
            16.2.4.2    Product Portfolio
            16.2.4.3    Demographic Reach and Achievements
            16.2.4.4    Certifications
        16.2.5    Others
17    Key Trends and Developments in the Market

 

List of Key Figures and Tables

1.    Global Giant Cell Arteritis Treatment Market: Key Industry Highlights, 2018 and 2032
2.    Global Giant Cell Arteritis Treatment Historical Market: Breakup by Treatment Type (USD Billion), 2018-2023
3.    Global Giant Cell Arteritis Treatment Market Forecast: Breakup by Treatment Type (USD Billion), 2024-2032
4.    Global Giant Cell Arteritis Treatment Historical Market: Breakup by End Use (USD Billion), 2018-2023
5.    Global Giant Cell Arteritis Treatment Market Forecast: Breakup by End Use (USD Billion), 2024-2032
6.    Global Giant Cell Arteritis Treatment Historical Market: Breakup by Region (USD Billion), 2018-2023
7.    Global Giant Cell Arteritis Treatment Market Forecast: Breakup by Region (USD Billion), 2024-2032
8.    North America Giant Cell Arteritis Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
9.    North America Giant Cell Arteritis Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
10.    Europe Giant Cell Arteritis Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
11.    Europe Giant Cell Arteritis Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
12.    Asia Pacific Giant Cell Arteritis Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
13.    Asia Pacific Giant Cell Arteritis Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
14.    Latin America Giant Cell Arteritis Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
15.    Latin America Giant Cell Arteritis Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
16.    Middle East and Africa Giant Cell Arteritis Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
17.    Middle East and Africa Giant Cell Arteritis Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
18.    Global Giant Cell Arteritis Treatment Market Structure

Key Questions Answered in the Report

The global giant cell arteritis treatment market is expected to grow at a CAGR of 5.1%.

The major drivers of the industry, such as the increasing prevalence of the disease, rising disposable incomes, growing health consciousness, rapid urbanisation, and the growing elderly population, are expected to aid the market growth.

The key trend in the industry is the growing investments in the R&D activities of the healthcare sector.

The major regional markets for giant cell arteritis treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

The major treatment types of giant cell arteritis in the market are corticosteroid therapy and others (monoclonal antibody).

The leading end use sectors for giant cell arteritis treatment in the market are hospitals, clinics, and ASC’s, among others.

The key players in the market include F. Hoffmann-La Roche Ltd., Kiniksa Pharmaceuticals, Ltd., Teva Pharmaceutical Industries Ltd., and Tianjin Tianyao Pharmaceutical Co., Ltd., among others.

Analyst Review

The global giant cell arteritis treatment market is being driven by the rising prevalence of the disease. Aided by the growing elderly population, the market is expected to witness a healthy growth in the forecast period of 2024-2032, growing at a CAGR of 5.1%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on the treatment type, the market is broadly classified into corticosteroid therapy and others (monoclonal antibody). By end use, the market can be categorised into hospitals, clinics, and ASC’s, among others. The major regional markets for giant cell arteritis treatment  are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the market include F. Hoffmann-La Roche Ltd., Kiniksa Pharmaceuticals, Ltd., Teva Pharmaceutical Industries Ltd., and Tianjin Tianyao Pharmaceutical Co., Ltd., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER